
Seres Therapeutics: FDA Approval Straight Ahead (NASDAQ:MCRB)
Bet_Noire Tact is the knack of making a point without making an enemy.”― Isaac Newton. Today, we put Seres Therapeutics, Inc. (NASDAQ:MCRB) in the spotlight. If all goes well, the company will garner its first […]